# Celltrion

Celltrion is a Corporate Investor based in Incheon, South Korea.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Incheon, South Korea
- **Region:** Asia
- **Address:** 23, Academy-ro, Yeonsu-gu, Incheon, Republic of Korea
- **Founded:** 1991
- **Assets under management:** 15124 (Altss estimate)
- **Website:** www.celltrion.com
- **LinkedIn:** https://www.linkedin.com/company/celltrioninc

## Regulatory record

- **Reports private funds:** No

## About

Celltrion was established in 1991 by Seo Jung-jin as a South Korean biopharmaceutical company. It developed the world's first biosimilar monoclonal antibody and maintains both small-molecule and biologic operations. The company invests across direct secondaries, early-stage seed rounds, and growth equity. It holds controlling stakes in Celltrion Holdings and Celltrion Pharm while operating manufacturing assets in South Korea and the United States. Confirmed positions include long equity in its listed subsidiaries and a planned Global Healthcare Fund targeting biotech companies worldwide. Geographic reach centers on South Korea and North America. Celltrion reports 15,124 million USD in assets and employs staff across headquarters and R&D facilities in Incheon plus commercial offices in Jersey City. It maintains the Celltrion Welfare Foundation, established in 2006, which supports scholarships and medical aid in South Korea. January 2026: Seo Jung-jin addressed the J.P. Morgan Healthcare Conference on U.S. manufacturing expansion and 2027 Nasdaq listing plans. Celltrion operates through a holding-company structure in which Seo Jung-jin controls 98.13 percent of Celltrion Holdings, creating a direct ownership link between the listed operating company and family-controlled vehicles.

## Sectors

- Biotechnology
- Pharmaceuticals
- Healthcare

## Offices

- Branchburg, NJ, USA
- Jersey City, NJ, USA
- Songdo, Incheon, Republic of Korea

## People

- Seo Jung-jin — Founder and Chairman
- Seo Jin-seok — Co-Chairman and CEO
- Seo Jun-seok — Senior Vice Chairman and Head of North America

## Questions

### Who runs investment decisions at Celltrion?

Seo Jung-jin serves as Founder and Chairman. His eldest son Seo Jin-seok acts as Co-Chairman and CEO while younger son Seo Jun-seok heads North American operations.

### Does Celltrion participate in fund commitments or only direct deals?

The firm executes direct secondaries and early-stage investments. It also announced plans for a dedicated Global Healthcare Fund.

### Where does Celltrion maintain manufacturing and R&D facilities?

Primary sites sit in Incheon, South Korea, including the Global R&D Center opened in 2023. An additional manufacturing plant operates in Branchburg, New Jersey.

### What is Celltrion's known posture on co-investments alongside external GPs?

Historical records show Temasek Holdings as a past co-investor in Celltrion itself. Current strategy emphasizes proprietary direct holdings rather than third-party fund commitments.

## Related profiles

- [National Bank of Fujairah](https://altss.com/profile/national-bank-of-fujairah)
- [Kamehameha Schools](https://altss.com/profile/kamehameha-schools-ks)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/celltrion

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology